
In-Vitro Diagnostics (IVD) Market in BRIC (2010 - 2014)
The IVD markets of BRIC economies offer immense growth opportunities due to the increasing healthcare budgets in these nations, along with the increasing number of private corporate hospitals, and the rising income levels backed by a huge, untapped population bases.
Despite regulatory hurdles and other restraints such as low consumer awareness and the absence of regulations concerning patient safety, the BRIC IVD market is expected to grow from $2.9 billion in 2009 to $7.2 billion-$7.5 billion in 2014 at a CAGR of ~19%-20% from 2009 to 2014. In comparison, the growth rate of the global IVD market is pegged at only ~5%-6% in the next five years. Our research indicates that China is expected to command the largest IVD market among all BRIC economies.
Scope of the Report
This report categorizes the BRIC IVD market on the basis of:
Geography: Brazil, Russia, India and China
Diagnostic Services: Hematology, immunology, microbiology, molecular diagnostics, urine analysis, etc.
Each section will provide market data, market drivers, trends and opportunities, key players, and competitive outlook. This report will also provide more than 50 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides 20 company profiles for each of its sub-segments.
Read more...
Read also at Pharmaceutical Licensing NetworkRelated News Newer news items
Related Items Farmavita.Net - The Pharmaceutical Licensing Network |